<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/7A880967-770A-4227-A095-9FEE27D69242"><gtr:id>7A880967-770A-4227-A095-9FEE27D69242</gtr:id><gtr:name>Newtec Vascular Products Limited</gtr:name><gtr:address><gtr:line1>LIVERPOOL SCIENCE PARK , 131 MOUNT PLEASANT</gtr:line1><gtr:city>LIVERPOOL</gtr:city><gtr:postCode>L3 5TF</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7A880967-770A-4227-A095-9FEE27D69242" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>7A880967-770A-4227-A095-9FEE27D69242</gtr:id><gtr:name>Newtec Vascular Products Limited</gtr:name><gtr:address><gtr:line1>LIVERPOOL SCIENCE PARK , 131 MOUNT PLEASANT</gtr:line1><gtr:city>LIVERPOOL</gtr:city><gtr:postCode>L3 5TF</gtr:postCode><gtr:region>North West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>136017.0</gtr:offerGrant><gtr:projectCost>302261.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6E844B50-071C-41DF-8E39-33627344D409"><gtr:id>6E844B50-071C-41DF-8E39-33627344D409</gtr:id><gtr:firstName>Rob</gtr:firstName><gtr:surname>Carson</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=720690"><gtr:id>98C67571-22BD-4A21-9E60-2A11AD5BB5AA</gtr:id><gtr:title>Development of an innovative medical device to promote healthy blood flow in bypass surgery</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>GRD Development of Prototype</gtr:grantCategory><gtr:grantReference>720690</gtr:grantReference><gtr:abstractText>Cardiovascular diseases (CVD) account for ~31% of all global deaths. Atherosclerosis -
hardening &amp;amp; narrowing of the arteries thus restricting blood supply to essential organs - is the
dominant cause of CVD responsible for ~75% of all cardiovascular deaths. Surgeons perform
complex bypass graft surgery using sections of a patient?s own healthy vessels or synthetic
grafts to reconnect the blood supply when blood flow is restricted, however bypass graft
failure rates are staggeringly high (~50%). The primary cause is Smooth Muscle Cell
Neointimal Hyperplasia (SMCNIH), an overreaction of a natural healing process for the
vessel wall in response to the trauma of surgery. The severe overgrowth of scar tissue causes
the vessel lumen to narrow &amp;amp; constrain at the join thus restricting/blocking the blood flow -
resulting in a high risk of clot formation. ~2M vascular grafts are implanted globally p.a. at
&amp;gt;$8k/patient. Revision surgery after graft failure is expensive, carries further
morbidity/mortality risk &amp;amp; causes severe distress to patients.
Newtec recognises the major business opportunity that exists for a cost effective medical
device that addresses this problem. The novel patented technology is a metal-free, drug-free
device designed to support a vascular join &amp;amp; promote healthy healing following arterial or
venous bypass surgery, promoting optimal healing of the joined vessels through its unique bilayered
structure. PoC trials showed that the intimal hyperplasia (causing vessel lumen
narrowing) reduced by a significant 30-50% - demonstrating the potential for routine use. This
project will advance the tech to develop a validated ?works-like? ?looks-like? prototype to be
used in a first in man trial prior to commercialisation. The device will be targeted towards the
cardiovascular surgical device mkt (est. globally to reach ~$47.2bn by 2018) with initial
applications in vascular grafts, peripheral grafts &amp;amp; subsequently coronary artery bypass grafts.</gtr:abstractText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2015-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>136017</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">720690</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>